tiprankstipranks
Trending News
More News >
MeVis Medical Solutions (GB:0HI7)
:0HI7
Advertisement

MeVis Medical Solutions (0HI7) Price & Analysis

Compare
0 Followers

0HI7 Stock Chart & Stats


0HI7 FAQ

What was MeVis Medical Solutions’s price range in the past 12 months?
MeVis Medical Solutions lowest share price was €24.40 and its highest was €26.60 in the past 12 months.
    What is MeVis Medical Solutions’s market cap?
    MeVis Medical Solutions’s market cap is €45.14M.
      When is MeVis Medical Solutions’s upcoming earnings report date?
      MeVis Medical Solutions’s upcoming earnings report date is Feb 04, 2026 which is in 179 days.
        How were MeVis Medical Solutions’s earnings last quarter?
        Currently, no data Available
        Is MeVis Medical Solutions overvalued?
        According to Wall Street analysts MeVis Medical Solutions’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does MeVis Medical Solutions pay dividends?
          MeVis Medical Solutions does not currently pay dividends.
          What is MeVis Medical Solutions’s EPS estimate?
          MeVis Medical Solutions’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does MeVis Medical Solutions have?
          MeVis Medical Solutions has 1,820,000 shares outstanding.
            What happened to MeVis Medical Solutions’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of MeVis Medical Solutions?
            Currently, no hedge funds are holding shares in GB:0HI7

            MeVis Medical Solutions Stock Smart Score

            4
            Neutral
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Negative
            20 days / 200 days
            Momentum
            -2.34%
            12-Months-Change

            Fundamentals

            Return on Equity
            24.14%
            Trailing 12-Months
            Asset Growth
            -6.09%
            Trailing 12-Months

            Company Description

            MeVis Medical Solutions

            MeVis Medical Solutions AG develops, markets, and sells software for analyzing and evaluating image data to equipment manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological disorders. It offers X-ray modalities, including computed tomography, digital mammography, digital tomosynthesis, magnetic resonance imaging, and digital sonography; and provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. The company also offers three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians, as well as internet-based special applications in teleradiology. In addition, its services are used for technical visualization and online training. The company was founded in 1992 and is based in Bremen, Germany. MeVis Medical Solutions AG is a subsidiary of Varex Imaging Deutschland AG.

            MeVis Medical Solutions (0HI7) Earnings & Revenues

            Currently, no data available
            Please return soon. This page is being updated.
            Similar Stocks
            Company
            Price & Change
            Follow
            CompuGroup Medical
            NEXUS AG
            Pulsion Medical Systems
            STRATEC Biomedical
            Medios AG
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis